The massive blind spot in our quest for precision medicine
In short: We are on the verge of a healthcare revolution, yet our genetic blueprints are dangerously incomplete. Most genomic studies focus almost exclusively on people of European descent, leaving the vast majority of the human population out of the scientific equation and potentially stalling medical progress.
The promise of precision medicine lies in tailoring treatments to an individual's unique genetic makeup. By identifying specific genetic markers, doctors can diagnose diseases or select the most effective drugs. However, an analysis published in the journal Cell reveals a staggering imbalance in the data used to build these medical insights. Up to 2018, 78 percent of individuals included in genomic disease studies were of European descent. In contrast, only 10 percent were Asian, 2 percent were African, 1 percent were Hispanic, and less than 1 percent represented all other groups.
This lack of diversity is more than a social issue; it is a scientific failure. Researchers like evolutionary geneticist Sarah Tishkoff argue that this imbalance limits our fundamental understanding of the human genome. When we ignore diverse populations, we miss critical biological clues. For instance, studying mutations within West African populations provided insights into the PCSK9 gene, which regulates cholesterol. Such investigations ultimately produced a novel category of medicines providing advantages to every ethnic group.
The stakes are highest for polygenic diseases—conditions like hypertension or coronary artery disease that involve many genes and environmental factors. Identifying these genes is like searching for unknown needles in a haystack of 3 billion base pairs. While Mendelian diseases, such as Huntington's disease, are driven by single gene variants, polygenic diseases are far more common and complex. Without diverse datasets to conduct genome-wide association studies (GWAS), we risk developing medical breakthroughs that only work for a fraction of humanity.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Genomics Has a Diversity Problem
- Also: Human Genomics Research Has A Diversity Problem
- Also: engineering.stanford.edu — Carlos Bustamante: Genomics has a diversity problem
To cite this card, link to https://intellectplus.co.uk/app/science-genomics-has-a-diversity-problem.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics
